These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
571 related articles for article (PubMed ID: 33266235)
1. Bile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome. Portincasa P; Di Ciaula A; Garruti G; Vacca M; De Angelis M; Wang DQ Nutrients; 2020 Nov; 12(12):. PubMed ID: 33266235 [TBL] [Abstract][Full Text] [Related]
2. Bile acids and their receptors during liver regeneration: "Dangerous protectors". Merlen G; Ursic-Bedoya J; Jourdainne V; Kahale N; Glenisson M; Doignon I; Rainteau D; Tordjmann T Mol Aspects Med; 2017 Aug; 56():25-33. PubMed ID: 28302491 [TBL] [Abstract][Full Text] [Related]
3. Hepatoprotective impact of the bile acid receptor TGR5. Merlen G; Bidault-Jourdainne V; Kahale N; Glenisson M; Ursic-Bedoya J; Doignon I; Garcin I; Humbert L; Rainteau D; Tordjmann T Liver Int; 2020 May; 40(5):1005-1015. PubMed ID: 32145703 [TBL] [Abstract][Full Text] [Related]
4. Bile acids as regulators of hepatic lipid and glucose metabolism. Trauner M; Claudel T; Fickert P; Moustafa T; Wagner M Dig Dis; 2010; 28(1):220-4. PubMed ID: 20460915 [TBL] [Abstract][Full Text] [Related]
5. Recent Advances in the Digestive, Metabolic and Therapeutic Effects of Farnesoid X Receptor and Fibroblast Growth Factor 19: From Cholesterol to Bile Acid Signaling. Di Ciaula A; Bonfrate L; Baj J; Khalil M; Garruti G; Stellaard F; Wang HH; Wang DQ; Portincasa P Nutrients; 2022 Nov; 14(23):. PubMed ID: 36500979 [TBL] [Abstract][Full Text] [Related]
6. The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease. Di Ciaula A; Bonfrate L; Khalil M; Portincasa P Intern Emerg Med; 2023 Nov; 18(8):2181-2197. PubMed ID: 37515676 [TBL] [Abstract][Full Text] [Related]
7. Bile Acid Physiology. Di Ciaula A; Garruti G; Lunardi Baccetto R; Molina-Molina E; Bonfrate L; Wang DQ; Portincasa P Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s4-s14. PubMed ID: 29080336 [TBL] [Abstract][Full Text] [Related]
8. Bile acids and their receptors. Martinot E; Sèdes L; Baptissart M; Lobaccaro JM; Caira F; Beaudoin C; Volle DH Mol Aspects Med; 2017 Aug; 56():2-9. PubMed ID: 28153453 [TBL] [Abstract][Full Text] [Related]
9. Bile acid receptors in the biliary tree: TGR5 in physiology and disease. Deutschmann K; Reich M; Klindt C; Dröge C; Spomer L; Häussinger D; Keitel V Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1319-1325. PubMed ID: 28844960 [TBL] [Abstract][Full Text] [Related]
10. Hepatic Bile Acid Reuptake in the Rat Depends on Bile Acid Conjugation but Not on Agonistic Properties towards FXR and TGR5. Trammell SAJ; Svenningsen JS; Holst JJ; Gillum MP; Kuhre RE Molecules; 2020 May; 25(10):. PubMed ID: 32443832 [TBL] [Abstract][Full Text] [Related]
11. Digestive physiology of the pig symposium: intestinal bile acid sensing is linked to key endocrine and metabolic signaling pathways. Burrin D; Stoll B; Moore D J Anim Sci; 2013 May; 91(5):1991-2000. PubMed ID: 23729782 [TBL] [Abstract][Full Text] [Related]
12. Gut microbiota-bile acid-intestinal Farnesoid X receptor signaling axis orchestrates cadmium-induced liver injury. Liu Y; Kang W; Liu S; Li J; Liu J; Chen X; Gan F; Huang K Sci Total Environ; 2022 Nov; 849():157861. PubMed ID: 35934034 [TBL] [Abstract][Full Text] [Related]
13. The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice. Péan N; Doignon I; Garcin I; Besnard A; Julien B; Liu B; Branchereau S; Spraul A; Guettier C; Humbert L; Schoonjans K; Rainteau D; Tordjmann T Hepatology; 2013 Oct; 58(4):1451-60. PubMed ID: 23686672 [TBL] [Abstract][Full Text] [Related]
14. Interactions between gut bacteria and bile in health and disease. Long SL; Gahan CGM; Joyce SA Mol Aspects Med; 2017 Aug; 56():54-65. PubMed ID: 28602676 [TBL] [Abstract][Full Text] [Related]
15. Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice. Liu Y; Chen K; Li F; Gu Z; Liu Q; He L; Shao T; Song Q; Zhu F; Zhang L; Jiang M; Zhou Y; Barve S; Zhang X; McClain CJ; Feng W Hepatology; 2020 Jun; 71(6):2050-2066. PubMed ID: 31571251 [TBL] [Abstract][Full Text] [Related]
16. The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer. Sun L; Cai J; Gonzalez FJ Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):335-347. PubMed ID: 33568795 [TBL] [Abstract][Full Text] [Related]
17. Lupeol improves bile acid metabolism and metabolic dysfunction-associated steatotic liver disease in mice via FXR signaling pathway and gut-liver axis. Qin D; Pan P; Lyu B; Chen W; Gao Y Biomed Pharmacother; 2024 Aug; 177():116942. PubMed ID: 38889641 [TBL] [Abstract][Full Text] [Related]
18. Bile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseases. Stanimirov B; Stankov K; Mikov M Hepatobiliary Pancreat Dis Int; 2015 Feb; 14(1):18-33. PubMed ID: 25655287 [TBL] [Abstract][Full Text] [Related]